PCN51 OUTCOMES MANAGEMENT IN A REAL WORLD EVIDENCE CONTEXT. THE CASE OF ABIRATERONE AND ENZALUTAMIDE IN THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.248
https://www.valueinhealthjournal.com/article/S1098-3015(19)32626-9/fulltext
Title :
PCN51 OUTCOMES MANAGEMENT IN A REAL WORLD EVIDENCE CONTEXT. THE CASE OF ABIRATERONE AND ENZALUTAMIDE IN THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32626-9&doi=10.1016/j.jval.2019.09.248
First page :
Section Title :
Open access? :
No
Section Order :
10194